<DOC>
	<DOCNO>NCT01458639</DOCNO>
	<brief_summary>Phase 3 within-subject trial Technegas V/Q SPECT Tc-99m macro-aggregated albumin ( MAA ) image compare Xenon-133 V/Q planar Tc-99m macroaggregate albumin ( MAA ) image diagnosis Pulmonary Embolism ( PE ) .</brief_summary>
	<brief_title>Compare Technegas Ventilation-Perfusion SPECT Xenon Ventilation-Perfusion Planar Imaging Pulmonary Embolism</brief_title>
	<detailed_description>This Phase 3 within-subject trial Technegas Ventilation SPECT Tc-99m MAA perfusion image compare xenon ( Xe-133 ) Ventilation Planar Tc-99m MAA perfusion image diagnosis PE . Diagnosis PE provide review subject ' document clinical information 30 day follow-up . Primary assessment efficacy base independent blind read Technegas V/Q SPECT image three different reader independent blind read Xe 133 V/Q planar image three different reader .</detailed_description>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Xenon</mesh_term>
	<criteria>Subjects enrol Cohort 1 meet following requirement : 1 . Male female , least 18 year age . 2 . Suspected PE candidate Xe133 V/Q image . 3 . Willing able provide inform consent . 4 . Stable able undergo Xe133 planar imaging , Technegas SPECT imaging , planar/SPECT perfusion image complete followup procedure . 5 . Willing agree complete study procedure , include followup safety assessment . 6 . Using adequate birth control , female fertile . 7 . If female , negative urine serum pregnancy test . 8 . Agrees return 24hour 30 day followup safety assessment . Subjects enrol Cohort 2 meet criterion AND subject likely pulmonary embolism base one following : 1 . Wells Score 7 great . Subjects Wells Score less 7 may enrol Cohort 2 agreement investigator medical monitor subject high risk PE . 2 . An abnormal Ddimer test . 3 . Positive Doppler ultrasound DVT . 4 . CTA positive PE within 24 hour image study . Subject 1 . Has undergone image Iodine131 ( I131 ) within 30 day , Thallium201 ( Tl201 ) Indium111 ( In111 ) within 10 day , Fluorine 18 ( F18 ) within 24 hour , radiopharmaceutical otherwise specify within 72 hour image study . 2 . Has previously undergone image study Tc99m agent , within 48 hour image study . 3 . Is pregnant lactate female . 4 . Has receive Technegas past . 5 . Was previously enrol another investigational study receive investigational drug within 30 day prior dose . 6 . Is hemodynamically unstable . 7 . Has receive therapeutic dose low molecular weight unfractionated heparin within 24 hour prior dose Tissue Plasminogen Activator ( tPA ) within 4 hour prior dose receive treatment PE time positive CTA , perform , Technegas V/Q SPECT imaging .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pulmonary embolism</keyword>
	<keyword>PE</keyword>
</DOC>